2-iminobiotin regulatory update

EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for Neurophyxia's 2-iminobiotin to treat perinatal asphyxia (oxygen shortage at birth)....